ArticleACS omega2019
Facile Preparation of Hierarchical AgNP-Loaded MXene/Fe
Article in ACS omega, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed.
- MXene-chitosan nanocomposites for structure interface and biofunctional applications in biosensing biocatalysis and regenerative biotechnology.Bioprocess and biosystems engineering · 2026Review
- The Future of MXene Fibers.Advanced materials (Deerfield Beach, Fla.) · 2025Article
- PEGylated MXene@AgNP nanocomposite for targeted release of docetaxel to breast carcinoma.Therapeutic delivery · 2025Article
- Facile synthesis of anthranilic acid based dual functionalized novel hyper cross-linked polymer for promising COScientific reports · 2024Article
- MXenes-polymer nanocomposites for biomedical applications: fundamentals and future perspectives.Frontiers in chemistry · 2024Review
- MXene Clay (Ti2C)-Containing In Situ Polymerized Hollow Core-Shell Binder for Silicon-Based Anodes in Lithium-Ion Batteries.ACS omega · 2023Article
- Biosynthesis, characterization, and investigation of antimicrobial and cytotoxic activities of silver nanoparticles usingHeliyon · 2023Article
- Electrospun Nanofiber Membrane: An Efficient and Environmentally Friendly Material for the Removal of Metals and Dyes.Molecules (Basel, Switzerland) · 2023Review
- Recent Progress in Silicon-Based Materials for Performance-Enhanced Lithium-Ion Batteries.Molecules (Basel, Switzerland) · 2023Review
- Characterization and Therapeutic Applications of Biosynthesized Silver Nanoparticles UsingPlants (Basel, Switzerland) · 2023Article
- Emergence of MXene and MXene-Polymer Hybrid Membranes as Future- Environmental Remediation Strategies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022Review
- Spiroheterocyclic Photocatalyst for Reducing QHIn-Persistent Pollutants, Dyes, and Transition-Metal Ions Cocatalyzed with Electrolytes.ACS omega · 2022Article
- Advancements in MXene-Polymer Nanocomposites in Energy Storage and Biomedical Applications.Polymers · 2022Review
- Surface Functionalized MXenes for Wastewater Treatment-A Comprehensive Review.Global challenges (Hoboken, NJ) · 2022Review
- Ultrasound-assisted fabrication of TiUltrasonics sonochemistry · 2022Article
- Review
- Research progress, models and simulation of electrospinning technology: a review.Journal of materials science · 2022Review
- Investigation of Antimicrobial and Cytotoxic Properties and Specification of Silver Nanoparticles (AgNPs) Derived FromFrontiers in bioengineering and biotechnology · 2022Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MXene as a kind of two-dimensional nanomaterial has aroused people's strong research interest because of its excellent properties. In the present study, we introduced a new poly(vinyl alcohol)/poly(acrylic acid)/Fe
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.